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a b s t r a c t
Herpes simplex virus 1 (HSV-1) infection induces changes to the host cell nucleus including relocaliza-
tion of the cellular protein Upstream Binding Factor (UBF) from the nucleolus to viral replication
compartments (VRCs). Herein, we tested the hypothesis that UBF is recruited to VRCs to promote viral
DNA replication. Surprisingly, infection of UBF-depleted HeLa cells with HSV-1 or HSV-2 produced
higher viral titers compared to controls. Reduced expression of UBF also led to a progressive increase in
the relative amount of HSV-1 DNA versus controls, and increased levels of HSV-1 ICP27 and TKmRNA and
protein, regardless of whether viral DNA replication was inhibited or not. Our results suggest that UBF
can inhibit gene expression from viral DNA prior to its replication. A similar but smaller effect on viral
titers was observed in human foreskin ﬁbroblasts. This is the ﬁrst report of UBF having a restrictive effect
on replication of a virus.
& 2015 Elsevier Inc. All rights reserved.
Introduction
The nucleolus is involved in many cellular functions, such as
ribosome biogenesis, cell cycle regulation, and stress responses (Sirri
et al., 2008; Boisvert et al., 2007; Boulon et al., 2010). The crucial
function of transcribing ribosomal RNA genes to serve in ribosome
biogenesis is ensured by the RNA polymerase I (PolI) complex. The
nucleolar protein Upstream Binding Factor (UBF) is one of the required
components to achieve rRNA production. At the extreme N-terminus
is a dimerization domain through which UBF can form homo- or
heterodimers, while the C-terminal part of the protein contains a
stretch of acidic amino acids. The central portion of UBF is composed
of six DNA-binding High Mobility Group (HMG) boxes through which
it binds to rDNA. This DNA binding aids the recruitment of PolI and
pre-rRNA processing components, and activates transcription (Learned
et al., 1986; Bell et al., 1988; Hanada et al., 1996; Tuan et al., 1999;
Prieto and McStay, 2007; Mais et al., 2005; Jantzen et al., 1990). UBF
also promotes rRNA synthesis by stimulating promoter escape and
transcript elongation (Panov et al., 2006; Stefanovsky et al., 2006).
Moreover, UBF regulates rDNA transcription in response to growth
factors and cell cycle progression (Stefanovsky et al., 2006; Stefanovsky
and Moss, 2008; Sanij et al., 2008; Voit et al., 1999; Stefanovsky et al.,
2001; Meraner et al., 2006). Interestingly, the binding of UBF to DNA
does not seem to be restricted to speciﬁc nucleotide sequences; UBF
may also recognize structural features of nucleic acids (Copenhaver
et al., 1994; Kuhn et al., 1994; O’Sullivan et al., 2002). The binding of
UBF to cellular DNA has the potential to alter chromatin by inducing
chromatin remodeling and the formation of looped structures similar
to nucleosomes termed “enhancesomes” (Stefanovsky et al., 2001;
Putnam et al., 1994; Stefanovsky et al., 1996; Chen et al., 2004;
Stefanovsky et al., 2006; Sanij and Hannan, 2009; Bazett-Jones et al.,
1994). Two isoforms of UBF, UBF1 and UBF2, are produced by
differential splicing (O’Mahony and Rothblum, 1991). Compared to
UBF1, UBF2 has a deletion of 37 amino acids near the end of the
second HMG box. This deletion alters the DNA binding characteristics
of UBF2, and is believed to affect its role in rDNA transcription
regulation (Stefanovsky and Moss, 2008).
UBF has been shown to be involved in the replication of several
viruses (reviewed in Hiscox et al., 2010; Greco, 2009; Hiscox, 2002).
For example, hepatitis C virus (HCV) induces the phosphorylation of
UBF, which stimulates the formation of the PolI transcription complex
leading to increased rRNA production (Kao et al., 2004; Raychaudhuri
et al., 2009). This increase in rRNA is in line with the ability of HCV to
promote cell growth and proliferation. Another example is the use of
UBF by adenovirus to stimulate viral replication. It has been suggested
that the interaction of UBF with the ends of the viral genome
promotes its replication (Lawrence et al., 2006).
HSV-1 carries out a major part of its replication cycle in the
nucleus. The formation of Viral Replication Compartments (VRCs)
and the action of several viral proteins induce many changes to the
nucleus and nucleolus. Host cell chromatin is marginalized at the
periphery of the nucleus (Monier et al., 2000), ND10 bodies are
dispersed, which prevents their inhibition of viral replication
(Maul et al., 1993; Everett et al., 1998; Glass and Everett, 2013;
Tavalai and Stamminger, 2009; Boutell and Everett, 2013), and
rRNA synthesis and maturation is altered (Wagner and Roizman,
1969; Besse and Puvion-Dutilleul, 1996; Belin et al., 2010). Several
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viral proteins have been shown to localize to, and interact with the
nucleolus including US11, ICP0, ICP34.5, UL24 and UL27.5
(MacLean et al., 1987; Morency et al., 2005; Salsman et al.,
2008). We have previously reported that the viral protein UL24
induces the diffusion of nucleolin and B23 throughout the nucleus
(Lymberopoulos and Pearson, 2007; Lymberopoulos et al., 2011).
We and others also observed that the nucleolar protein UBF
relocalizes to VRCs (Stow et al., 2009; Lymberopoulos and
Pearson, 2010) shortly after the onset of viral DNA synthesis and
in conjunction with the PolI subunit RPA194 (Lymberopoulos and
Pearson, 2010). The mechanisms involved in this relocalization
and the functions of UBF in HSV-1 replication are not yet known,
although its relocalization is independent of UL24. One model that
has been proposed is that UBF has a direct role in viral DNA
synthesis (Stow et al., 2009), such as seen in adenovirus replica-
tion where UBF is also recruited to VRCs (Lawrence et al., 2006).
Given that UBF relocalizes to VRCs, and its DNA-binding proper-
ties, we hypothesized that UBF is involved in the replication of
HSV-1. To test this hypothesis, we used an siRNA approach to
knock-down the expression of UBF. We subsequently infected
knocked-down cells, and assessed the impact on viral replication.
Results
Knock-down of UBF causes increased HSV-1 titers
To assess the functional role of UBF during infection in human
cells, an siRNA approach to knock-down levels of UBF protein was
chosen. HeLa cells were transfected with siRNA targeting the open
reading frame of UBF. To eliminate the potential risk of observing
off-target effects on either cellular or viral mRNAs, siRNAs from
two manufacturers having different targets within UBF were used.
The target sites for the four siRNAs from Dharmacon and the three
from Invitrogen—Life Technologies are shown in Fig. 1. Non-
targeting siRNAs from each manufacturer were used as negative
controls. The sequences of both the UBF-speciﬁc and the non-
targeting controls were also checked against the HSV-1 KOS
genome. As shown in Fig. 1A, all siRNAs target the open reading
frame of the three known mRNA transcripts for UBF.
HeLa cells were either non-transfected, transfected with the
UBF-targeting siRNAs or else with the appropriate control siRNAs
for 48 h. Nucleic acid staining using SYTOX Green nucleic acid
stain showed a viability of more than 85% 48 h after transfection
(data not shown). siRNAs from Dharmacon were tested individu-
ally and as a pool for their knock-down efﬁciency. To conﬁrm the
knock-down of UBF expression, protein levels were assessed by
Western blot (Fig. 1B). A successful knock-down was established
48 h post-transfection in cells transfected with UBF-targeting
siRNAs compared to both controls, and the knock-down was more
pronounced in cells transfected with pooled siRNAs. For all
subsequent experiments, cells were transfected for 48 h with
pooled siRNAs prior to further experimentation. In order to test
the importance of UBF for HSV-1 replication, control and trans-
fected cells were infected with the HSV-1 strain KOS at an MOI of
5 for 18 h, and infectious viral particles (cell-associated and cell-
free) were quantiﬁed by titration assay on Vero cells. In this, and
all subsequent experiments, small variations in titers between
control cells and non-targeting controls were not statistically
signiﬁcant. Surprisingly, we found that viral titers were increased
approximately ten-fold in UBF-knocked-down cells compared to
controls. We obtained similar results using either set of UBF-
targeting siRNAs (Fig. 2A and B). This increase in infectious
particles suggests that UBF might interfere with the viral replica-
tion cycle, as opposed to contributing to viral DNA synthesis.
To conﬁrm that reducing UBF levels leads to an increase in viral
gene products and not only the production of more infectious
particles, we tested whether there was an increase in viral
structural proteins by Western blot. We found that the level of
structural HSV-1 proteins was increased in UBF-knocked-down
cells compared to controls at 10 and 15 hpi (Fig. 3). This result
supports the notion that the increase in viral titers observed in
cells knocked-down for UBF is the result of an increase in the
synthesis of viral gene products.
Increase in viral DNA synthesis in cells knocked-down for UBF
Based on our results, we next tested the hypothesis that UBF
has a negative effect on HSV-1 DNA replication. We used qPCR to
quantify viral DNA in cells treated with various siRNAs. Forty-eight
hours post-transfection with UBF-targeting or non-targeting siR-
NAs, cells were infected at an MOI of 5 with KOS. At 1, 5, 10 and 15
Fig. 1. Description of the siRNA approach. (A) Graphic representation showing an alignment of the speciﬁc siRNAs with the three known UBF mRNAs. The thick black lines
represent the 50 portions of the three different UBF mRNA species. Target sites are indicated with arrows for Dharmacon siRNAs and with asterisks for Invitrogen—Life
Technologies siRNAs. All target sites are present on the three UBF mRNA species and fall within the open reading frame, which begins at nucleotide position 297. (B) Western
blot analysis of UBF levels following siRNA treatment. Dharmacon siRNAs against UBF (siUBF) were tested individually and pooled. Non-targeting siRNAs (siNT) were used as
a negative control. Invitrogen siRNAs A–C targeting UBF were tested pooled (siABC). Non-transfected cells (C) and cells transfected with non-targeting siRNAs (siNeg) served
as negative controls. Cells were transfected with UBF-targeting siRNAs or non-targeting siRNAs for 48 h prior to analysis. Top panel showsWestern blot for UBF, bottom panel
shows blot for the loading control tubulin. The positions of molecular mass markers are indicated to the left of the panels.
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hpi, total DNA was extracted and ampliﬁed by qPCR. Fig. 4 shows
the fold increase of viral DNA in UBF-knocked-down cells com-
pared to control cells transfected with non-targeting siRNAs. As
expected, at 1 hpi, prior to viral DNA replication, the input
genomes were present in similar amounts in UBF-knocked-down
and in control cells. We detected a modest increase in the relative
amount of viral DNA in UBF-knocked-down cells compared to the
control as early as 5 hpi. The increase in the ratio of accumulated
viral DNA in UBF-knocked-down cells compared to the control
rose in magnitude at 10 and 15 hpi, reaching 6- and 13-fold
respectively. To conﬁrm that the observed result was caused by an
increase in DNA synthesis and not a reduction in viral DNA
degradation in UBF-knocked-down cells, the same experiment
was carried out in the presence of the HSV DNA replication
inhibitor phosphonoacetic acid (PAA). In the absence of viral
DNA replication, the ratio of viral DNA in UBF-knocked-down cells
compared to the controls remained stable. Taken together, these
results suggest that UBF hinders rather than promotes viral DNA
production, and that this restriction is maintained during the
infectious cycle, because the ratio of viral DNA between UBF-
knocked-down cells and control cells increased over time.
Levels of IE and E viral gene products are affected by UBF
The DNA-binding properties of UBF would be consistent with
two hypotheses; the reduction in viral DNA production could be a
result of UBF directly hindering viral DNA replication, or it could
be an indirect effect due to an inhibitory effect on viral transcrip-
tion, leading to lower amounts of proteins required for viral DNA
replication. To test these hypotheses, we ﬁrst analyzed the effect of
UBF on the production of representative immediate-early (IE) and
early (E) viral gene products.
The IE protein ICP27 is a multifunctional regulator that plays an
important role in regulating expression of proteins including,
among others, those required for viral DNA synthesis. TK is
encoded by an E gene; it is used in the production of nucleoside
triphosphates required for viral DNA synthesis. The early protein
ICP8 is the viral single strand DNA-binding protein and is critical
for HSV-1 DNA replication. HeLa cells were non-transfected or
transfected with non-targeting siRNAs as negative controls, or
transfected with siRNAs targeting UBF as described above. Forty-
eight hours post-transfection, cells were infected with KOS at an
MOI of 5. Cell lysates were prepared from cells at 5, 10 and 15 hpi
and analyzed by Western blot (Fig. 5A and B). In cells knocked-
down for UBF, higher amounts of ICP27, TK and ICP8 compared to
controls were detected at 5 hpi. We concluded that viral IE and E
protein accumulation is diminished in the presence of UBF.
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Fig. 2. Increased production of infectious viral particles in cells knocked-down for UBF.
HeLa cells were non-transfected (C) or transfected as previously described with a
pool of non-targeting or UBF-targeting siRNAs from Dharmacon (A) and Invitrogen
(B). After 48 h, cells were infected with KOS at an MOI of 5. Total viral particles were
harvested 18 h post-infection and quantiﬁed by plaque titration. Error bars
represent the standard deviation from the mean of three independent experiments.
Fig. 3. Increased amount of structural proteins in cells knocked-down for UBF
compared to negative controls. Cells were non-transfected (C), transfected with
non-targeting siRNAs (siNT) or transfected with UBF-targeting siRNAs (siUBF) for
48 h. Cells were mock-infected (M) or infected with KOS at a MOI of 5. Cell lysates
were prepared at the indicated time points. Proteins were analyzed by Western
blotting using a polyclonal antibody directed against HSV-1 structural proteins.
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Fig. 4. Impact of UBF on viral DNA synthesis during infection. Data points represent
fold increase in viral DNA produced in UBF-depleted cells in comparison to the
non-targeting control. HeLa cells previously transfected with UBF-targeting or non-
targeting siRNAs were infected at an MOI of 5 with KOS, in the presence or absence
of PAA. Total DNAwas extracted at the indicated time points. Relative quantiﬁcation
was performed by qPCR using primers for the viral gene ICP4 (Kramer and Coen,
1995). The cellular gene RNAseP served to normalise the results (McNees et al.,
2005). Error bars represent standard deviation from the mean of three independent
experiments.
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To determine whether UBF affected viral protein expression at
the transcript level, viral transcripts were quantiﬁed by qPCR. HeLa
cells were transfected with UBF-speciﬁc siRNAs or controls and
infected as described above. At 5 hpi, total RNA was extracted and
reverse transcribed to cDNA. Relative quantiﬁcation was done by
qPCR and viral transcript levels were normalized with a cellular
housekeeping gene (GAPDH). Fig. 5C shows the relative increase of
transcript levels in UBF-knocked-down cells compared to the non-
targeting control. In UBF-knocked-down cells, ICP27 mRNA was
increased more than two-fold and TK mRNA was increased
approximately ﬁfteen-fold. We concluded that UBF restricts the
accumulation of viral transcripts at early times in infection.
UBF limits the accumulation of viral products from input genomes
Our results showing the increase in IE and E viral gene products
could be explained by an effect of UBF on DNA replication, which
would affect the number of templates available for viral transcription,
or it could be due in part to a direct effect on the input genomes.
To determine if the increase in viral proteins can be detected in the
absence of an increase in viral genomes, we treated cells with PAA.
Forty-eight hours post-transfection of siRNAs, cells were infected with
KOS at an MOI of 5 in the presence of PAA. Consequently, any effect
observed in UBF-knocked-down cells would not depend on differ-
ences in levels of viral DNA. The effect of PAA was conﬁrmed by the
absence of expression of the true-late protein gC (Fig. 6A).
We found that even when blocking viral DNA synthesis, knock-
down of UBF expression led to increased amount of ICP27 and TK
proteins and transcripts at 5 hpi (Fig. 6A and B). Similar results were
obtained for the early HSV-1 protein ICP8 (data not shown). Transcript
levels were increased approximately two-fold for ICP27 and almost
15-fold for TK. From these results, we conclude that UBF negatively
affects the levels of IE and E mRNA and proteins produced from the
input genomes. We noted that the effect on ICP27 was less pro-
nounced than what we observed when viral DNA synthesis was
allowed to proceed. Thus, in our original knock-down experiments,
the increase in the levels of viral transcripts and proteins appears to be
a combination of a direct effect on the input genomes and an indirect
effect due to changes in levels of viral genomes in infected cells.
Regardless, even in the presence of PAA there were notably higher
levels of TK protein at 5, 10 and 15 hpi, and of TK mRNA at 5 hpi
(Fig. 6). Therefore, we conclude that UBF is able to reduce the
accumulation of viral transcripts expressed from the input genomes,
independently of an effect on viral DNA replication.
UBF is redistributed to sites other than pre-VRCs before relocalization
to VRCs
Because the effect of UBF was detected in the absence of viral DNA
replication, and based on our previous observation that viral DNA
replication precedes the recruitment of UBF to VRCs, we tested directly
whether UBF was recruited to pre-VRCs prior to relocalizing to VRCs.
In addition to HeLa cells (Suppl. Fig. S1), we carried out the experiment
in Vero cells (Fig. 7), which have been used extensively to study VRC
formation, and inwhich we were able to better visualize the evolution
of these structures early in infection than in HeLa cells. Mock-infected
cells or cells at 1, 3, 5, and 7 hpi in the presence or absence of PAA
were ﬁxed and processed for IF co-staining of ICP8 and UBF. In both
HeLa and Vero cells, UBF redistribution was detected by 3 hpi in the
presence or absence of PAA. In HeLa cells, ICP8 staining remained
mainly diffuse until 7 hpi when VRCs formed in which UBF staining
was observed. In Vero cells, we observed formation of what appeared
to be pre-VRCs at 3 hpi, and then the growing VRCs. As expected, in
the presence of PAA VRC formation was inhibited and ICP8 staining
remained diffuse in the nucleoplasm with a few small intense spots
detected. 3-D images compiled from Z-stacks revealed that UBF and
ICP8 did not colocalize in the absence or presence of PAA in Vero cells
at 3 hpi (Suppl. Videos S1 and S2). This latter result demonstrates that
UBF is initially redistributed to nuclear subdomains other than pre-
VRCs and that HSV DNA synthesis appears to trigger UBF relocalization
to VRCs.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.virol.2015.04.003.
UBF restricts HSV-2 replication
To determine whether the effect of UBF on KOS replication was
speciﬁc to HSV-1, HeLa cells were transfected as described in previous
Fig. 5. Increased production of immediate-early and early HSV-1 gene products in UBF-depleted cells. HeLa cells were non-transfected (C), or transfected with either the non-
targeting (siNT) or the UBF-targeting siRNAs (siUBF). After 48 h, cells were either mock-infected (M) or infected with KOS at an MOI of 5. (A) Western blot analysis of viral
protein accumulation in UBF-depleted cells. Cell lysates were prepared at the indicated time points and resolved by SDS-PAGE. The top panel shows UBF levels, and the
bottom panel shows tubulin, the loading control. The middle panels show Western blot results for the immediate-early viral protein ICP27 and the early protein TK.
(B) Western blot showing steady-state levels of the early viral protein ICP8 in HSV-1-infected HeLa cells depleted for UBF. (C) Relative quantiﬁcation of viral transcripts. Total
mRNAwas extracted at 5 hpi and analyzed by RT-qPCR. Bars represent the fold increase in mRNA levels between UBF-knocked-down cells and cells transfected with the non-
targeting control. Error bars represent standard deviation from three independent experiments.
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experiments, and subsequently infected with the HSV-2 strain HG52
at an MOI of 5. Cells were lysed at 18 hpi, and infectious viral particles
were quantiﬁed by titration assay (Fig. 8). In UBF-knocked-down cells,
we observed a rise in viral titers for HSV-2 that was similar to that
observed for HSV-1. Thus, our results suggest that restriction of viral
replication by UBF is not speciﬁc to HSV-1, but is a phenomenon that
can be generalized to a second human herpesvirus, HSV-2.
UBF affects viral replication in non-transformed cells
We next assessed if the inhibition of viral replication by UBF was
limited to HeLa cells by depleting UBF in a non-transformed cell line.
The expression of UBF was knocked-down in human foreskin ﬁbro-
blasts (HFF) as described for the previous experiments, and was
conﬁrmed by Western blotting (data not shown). We observed a
statistically signiﬁcant increase of more than 45% in viral titers
produced from UBF-knocked-down cells compared to non-targeting
control cells. The magnitude of the effect on HSV-1 caused by
depleting UBF in the non-transformed cells was lower than that seen
in HeLa cells. Nevertheless, these results demonstrate that the negative
effect of UBF on HSV-1 replication is not limited exclusively to
HeLa cells.
Discussion
UBF restricts HSV replication in cell culture
Prior to undertaking this study, it had been proposed that UBF
functions either directly or indirectly to promote HSV DNA replication
similar to what has been reported for adenovirus DNA replication
(Lawrence et al., 2006). It was observed that overexpression of UBF
negatively affected HSV-1 origin-dependent DNA synthesis in a co-
transfection experiment (Stow et al., 2009), which was interpreted to
reﬂect the importance of UBF for HSV-1 DNA replication. The
relocalization of UBF to foci within viral replication compartments
(Stow et al., 2009; Lymberopoulos and Pearson, 2010) was consistent
with this model; however, the observation that compartments of DNA
synthesis were readily observed prior to relocalization of UBF foci to
VRCs suggested that at least early HSV DNA replication does not
depend on UBF. Our recent results, including our observation that UBF
does not relocalize to pre-VRCs, also do not support a model whereby
UBF promotes HSV replication. Rather our data demonstrate that UBF
has an inhibitory effect on HSV yield. Our discovery that HSV-1 titers
are higher in cells where UBF expression has been reduced via siRNA
knock-down was observed using two different sets of siRNAs that
target different sites within the UBF ORF. This result strongly suggests
that the increase in the production of infectious virus is attributable to
the reduction in cellular UBF levels, and not an off-target effect.
Furthermore, this impact of UBF on infection is not a peculiarity of
the HSV-1 strain used, namely KOS, because we observed the same
effect for a different virus, HSV-2. We have also shown that the effect
mediated by UBF is present in HFFs, a non-transformed cell line. We
noted that the increase in viral titers in UBF-depleted HFFs was not as
high as that observed in HeLa cells. Similar disparities between cell
lines with regards to host-antiviral responses have been reported in
the past, including differences between non-transformed and cancer-
ous cell lines (Kalamvoki and Roizman, 2014). Thus, we have identiﬁed
a novel role for UBF in the host response against HSV.
UBF affects HSV replication at the level of viral mRNA accumulation
We found that reduced levels of UBF led to an increase in the levels
of viral gene products. The increase in viral transcripts and proteins
appears to be due to at least two factors. When levels of UBF were
reduced, we observed a progressive increase in levels of viral DNA.
This increase in template DNAwould be expected to lead to more viral
transcription, which in turn would lead to more mRNA available for
translation into viral proteins. It was previously reported that over-
expression of either wildtype UBF or fragments of UBF that retain DNA
binding domains reduce infectivity of puriﬁed HSV DNA (Stow et al.,
2009). The original interpretation of this experiment was that it
demonstrated a biological interaction between UBF and HSV, which
supported the model that UBF plays a role in HSV DNA replication. But
based on our results, we propose an alternate interpretation, namely
that it reﬂects an intrinsic inhibitory effect of UBF on HSV replication.
Although the increase in viral gene products is in part due to an
increase in viral DNA synthesis, we also observed an increase in
immediate-early and early viral gene expression even in the absence
of viral DNA synthesis due to the replication inhibitor PAA. We
conclude from these results that UBF negatively affects viral transcript
levels originating from input genomes. Previous observations by our
laboratory showed that inhibiting HSV-1 DNA replication with PAA
does not completely block the relocalization of UBF to VRCs
(Lymberopoulos and Pearson, 2010), which is also consistent with
the model that the UBF can somehow interact with HSV-1 genomes
prior to viral DNA synthesis. It should be noted however, that the
magnitude of the effect of UBF on HSV protein expression was greater
Fig. 6. Western blot analysis of viral protein levels in UBF-depleted and PAA-treated cells. HeLa cells were non-transfected (C), or transfected with either the non-targeting (siNT)
or the UBF-targeting siRNAs (siUBF). After 48 h, cells were either mock-infected (M) or infected with KOS at an MOI of 5, then treated with PAA. (A) Western blot analysis of
viral proteins in UBF-depleted cells treated with PAA. Cell lysates were prepared at the indicated time points and proteins resolved by SDS-PAGE. Staining was done as
described in Fig. 5A. Staining for the true late viral protein gC served as a control for the inhibition of viral DNA synthesis. The sample labeled with an asterisk originates from
the experiment shown in Fig. 5A, lane C at 15 hpi and serves as a positive staining control for gC. (B) Relative quantiﬁcation of viral transcripts produced in UBF-depleted cells
treated with PAA was done as described in Fig. 5B. Error bars represent standard deviation from three independent experiments.
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when viral DNA synthesis was allowed to proceed. Thus, we propose
that the biological effect of UBF is the combined consequence of
reducing viral transcript levels, and of reducing viral DNA synthesis,
either directly or indirectly through a reduction in the quantity of viral
replication proteins.
Possible mechanisms of UBF restriction of HSV replication
Given the intrinsic DNA-binding properties of UBF (Jantzen et al.,
1990; Copenhaver et al., 1994; Hu et al., 1998), one possible model for
how UBF restricts HSV replication is that UBF binds incoming viral
Fig. 7. UBF is redistributed to sites other than pre-VRCs before relocalization to VRCs in Vero cells. Vero cells were either mock-infected or infected with KOS at an MOI of 0.5 in
the absence (A) or presence (B) of PAA. Cells were ﬁxed at the indicated times post-infection, and analyzed by IF to co-stain for UBF (green) and ICP8 (red). Merge images are
in the right-hand panel of each set. Nuclei were stained with Draq5 (blue). The fourth row of images represents a close up of the boxed region in the corresponding image
from 3 hpi.
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DNA and reduces accessibility both to cellular and viral transcription
factors, and to the viral DNA replication machinery. Targeting of
incoming viral genomes is the strategy at play in the ND10-based
restriction of HSV-1 replication (Ishov and Maul, 1996; Maul et al.,
1996; Everett et al., 2007; Everett and Murray, 2005; Everett et al.,
2004), and in a growing number of other cellular antiviral responses
to HSV (Kalamvoki and Roizman, 2014; Orzalli et al., 2013; Ducroux
et al., 2014). Because the HSV-1 genome is not in the form of
chromatin when packaged into the capsid (Oh and Fraser, 2008;
Gibson and Roizman, 1971; Pignatti and Cassai, 1980), it is easily
accessible to DNA-binding proteins upon its release in the nucleus.
The nuclear DNA sensor IFN-inducible protein 16 (IFI16) has been
shown to relocalize to HSV-1 DNA and replication compartments
(Orzalli et al., 2013; Li et al., 2012; Johnson et al., 2014). IFI16
depletion promotes HSV-1 gene expression and reduces the accu-
mulation of repressive histone marks (Orzalli et al., 2013). It also
limits the association of RNA PolII and of several transcription factors
with transcription start sites (Johnson et al., 2014). Given the
characteristics of UBF and the results of this study, it is possible that
UBF functions in a similar manner, either independently or in
relation with an already identiﬁed pathway. As we and others have
proposed, UBF may recognize a speciﬁc structural feature of HSV
DNA. Alternatively, UBF may interact with viral DNA in a non-speciﬁc
manner.
Future work should address whether UBF interacts directly
with HSV DNA, and if so, what parameters govern the interactions.
Furthermore, based on studies with herpesviruses and other virus
families, we expect that HSV replication occurs despite UBF due to
the presence of viral effectors that counter its inhibitory activities,
and which remain to be identiﬁed. We have demonstrated that the
inhibitory effect of UBF extends at least from HSV-1 to HSV-2. It
will be interesting to determine if it represents a general inhibitor
of herpesvirus replication beyond the simplexviruses.
Materials and methods
Cells and viruses
HeLa and HFF cells were plated at a density of 2104 cells/cm2
the day prior to experiments. HeLa cells were cultured in Dulbec-
co's Modiﬁed Eagle's Media (DMEM) containing the antibiotics
penicillin and streptomycin and 8% fetal bovine serum (FBS). HFF
cells were cultured in DMEM containing the antibiotics penicillin
and streptomycin and 10% FBS. Vero cells were cultured in DMEM
containing 5% newborn calf serum (NCS) and the antibiotics
penicillin and streptomycin. All cells were maintained at 37 1C
with 5% CO2. The HSV-1 strain KOS and the HSV-2 strain HG-52
were originally provided by Donald M. Coen (Harvard Medical
School). Multiplicities of infection (MOI) are presented based on
titers obtained in Vero cells. An MOI of 0.5 was used in infection of
HFF and Vero cells to reﬂect the lower effective MOI in HeLa cells.
Where indicated, PAA treatment consisted of 300 mg/mL in
culture media.
Western blotting
Cells were washed with phosphate-buffered saline (PBS), and
lysed in 150 mL of RIPA lysis buffer (500 mM NaCl, 1% Triton X-100,
0.5% deoxycholic acid, 0.1% sodium dodecyl sulfate, and 50 mM Tris
[pH 7.5]). Protein lysates were resolved by SDS-PAGE with an
acrylamide concentration of 10%, and transferred to a polyvinylidene
diﬂuoride (PVDF) membrane for blotting (Immobilon-P; Millipore).
Antibodies directed against the following proteins were used: UBF
(mouse monoclonal, Santa Cruz Biotechnology), γ-Tubulin (rabbit
polyclonal, Sigma-Aldrich), ICP8 (mouse monoclonal, Santa Cruz
Biotechnology), TK (mouse monoclonal, produced by William Sum-
mers, Yale), ICP27 (mouse monoclonal, Fitzgerald, #10-H44), HSV-1
(rabbit polyclonal, Abcam) and gC (mouse monoclonal, Fitzgerald).
Anti-mouse (Jackson ImmunoResearch Laboratories) or anti-rabbit
(Bethyl) secondary goat antibodies conjugated to horseradish perox-
idase were used.
siRNA transfections
siGenome non-targeting siRNA pool and siGenome UBF-targeting
siRNAs were purchased from Dharmacon and resuspended according
to the manufacturer's protocol. Transfections were carried out using
2 mL of DharmaFECT 1 transfection reagent per well for 12-well plates,
or 4 mL per well for 6-well plates. HeLa and HFF cells were transfected
with a ﬁnal concentration of 25 nM of siRNA. Stealth siRNA targeting
UBF and negative control were purchased from Invitrogen—Life
Technologies. Transfections were carried out according to the manu-
facturer's protocol using 2 mL of Lipofectamine 2000 transfection
reagent per well for 12-well plates. HeLa cells were transfected with
a ﬁnal concentration of 40 nM of siRNA. For all siRNA transfections,
transfection media was replaced with culture media 8 h post-
transfection. Transfected cells were incubated for 48 h before further
use in experiments.
Transfected cells were tested for viability 48 h post-transfection
using the SYTOX Green nucleic acid stain (Invitrogen—Life Tech-
nologies). HeLa and HFF cells were stained according to the
manufacturer's protocol using a dye concentration of 500 nM.
DNA extraction, qPCR and RT-qPCR
DNA was extracted from infected cells with the Qiagen Blood and
Tissue Kit. qPCR was performed with Clontech SYBR Advantage qPCR
Premix using the following primers: RNaseP forward 50–CCT GAA GGC
TCT GCG CGGAC, reverse 50–CAG ACC AAC ACC TCG GCG GG; and ICP4
forward 50–CGA CAC GGA TCC ACG ACC C, reverse 50–GAT CCC CCT
CCC GCG CTT CGT CCG. ICP4 primer sequences have been published
previously (Kramer and Coen, 1995).
RNA extraction was performed with the BioBasic EZ-10 Spin
Column Total RNA Mini-Preps kit. RT-qPCR reactions were done in
two steps using the reverse transcription kit iScript cDNA Synthesis
and the qPCR mastermix iTaq Universal SYBR Green Supermix from
BioRad. The following qPCR primers were used: GAPDH forward: 50–
CTT CAC CAC CAT GGA GAA GGC, reverse: 50–GGC ATG GAC TGT GGT
CAT GAG; ICP27 forward: 50–TAA TTG ACC TCG GCC TGG AC, reverse:
50–GGG TCT TCC ATG TCC TCG TC; TK forward: 50–CCC AAC GGC GAC
CTG TAT AAC, reverse: 50–CCG GAG GTA AGT TGC AGC AG.
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Fig. 8. Increased production of HSV-2 infectious viral particles in UBF-depleted cells.
HeLa cells were non-transfected (C) or transfected as previously described with a
pool of non-targeting (siNT) or UBF-targeting siRNAs (siUBF). After 48 h, cells were
infected with the HSV-2 strain HG52 at a MOI of 5. Total viral particles were
harvested 18 h post-infection and quantiﬁed by plaque titration. Error bars
represents the standard error for two independent experiments.
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The qPCR reactions were performed on a Corbett Life Science
Rotor-Gene 3000 with the Rotor-Gene 6 software. The speciﬁcity
of the ampliﬁed products was conﬁrmed by the analysis of melt
curves. Relative quantiﬁcation of viral genomes and transcripts
was done using the 2ΔΔCT method (Livak and Schmittgen, 2001).
Confocal microscopy
Cells were processed for indirect immunoﬂuorescence experiments
(IF) essentially as described previously (Lymberopoulos and Pearson,
2010) using a primarymousemonoclonal antibody to ICP8 (Santa Cruz
Biotechnology) and a rabbit polyclonal antibody to UBF (Santa Cruz
Biotechnology), as well as secondary antibodies conjugated to Alexa
488 or Alexa 568. Slides were visualized using a Zeiss LSM 780
confocal and an Axio Observer Z1 (63X, N.A. 1.4) microscope with an
argon multi-line laser at 458/488/514 nm, a DPSS laser at 561 nm, and
a HeNe laser at 633 nm. Confocal images and z-stacks were processed
with the Zen Black 2011 software. Figures were assembled using
Adobe Illustrator and Photoshop CS5.
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